Inhaled Mannitol in CF

Long Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects DPM-CF-303


Purpose: An 18 week study looking to have Cystic Fibrosis patients administer Dry Powder Mannitol or Placebo and study lung health.

Sponsor: Pharmaxis

Principal Investigator: Cori Daines, MD

Contact Information:

Osmara Y. Molina de Rodriguez, MS

Cell: (520) 891-6767 or Office: (520) 626-3910

Study Status: 
Currently Enrolling